IALONGO, DAVIDE
 Distribuzione geografica
Continente #
EU - Europa 1.148
NA - Nord America 695
AS - Asia 457
OC - Oceania 32
AF - Africa 26
SA - Sud America 12
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.371
Nazione #
IT - Italia 718
US - Stati Uniti d'America 661
SG - Singapore 145
IN - India 77
RU - Federazione Russa 67
IE - Irlanda 60
DE - Germania 57
CN - Cina 48
FI - Finlandia 44
FR - Francia 39
KR - Corea 38
AU - Australia 32
CA - Canada 27
GB - Regno Unito 25
PK - Pakistan 25
BG - Bulgaria 24
NL - Olanda 21
TR - Turchia 19
IR - Iran 18
HK - Hong Kong 16
ES - Italia 15
JP - Giappone 15
SE - Svezia 14
EG - Egitto 13
GR - Grecia 13
ID - Indonesia 13
BR - Brasile 9
CH - Svizzera 9
TH - Thailandia 9
HU - Ungheria 8
CY - Cipro 6
UG - Uganda 6
BD - Bangladesh 5
MX - Messico 5
BE - Belgio 4
IL - Israele 4
MY - Malesia 4
PT - Portogallo 4
SA - Arabia Saudita 4
TW - Taiwan 4
AL - Albania 3
AR - Argentina 3
AT - Austria 3
LV - Lettonia 3
PL - Polonia 3
UA - Ucraina 3
CZ - Repubblica Ceca 2
JM - Giamaica 2
LT - Lituania 2
NG - Nigeria 2
NO - Norvegia 2
OM - Oman 2
RO - Romania 2
TG - Togo 2
VN - Vietnam 2
ZA - Sudafrica 2
AE - Emirati Arabi Uniti 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
DK - Danimarca 1
EE - Estonia 1
EU - Europa 1
PH - Filippine 1
UZ - Uzbekistan 1
Totale 2.371
Città #
Rome 308
Santa Clara 128
Singapore 98
Dublin 60
Philadelphia 45
Helsinki 38
Ashburn 29
Moscow 29
Chandler 28
Florence 26
Tampa 26
Fairfield 25
Sydney 21
New York 20
Milan 17
Boardman 16
Sofia 16
Karachi 14
Pessac 14
Ahmedabad 13
Jakarta 13
Palermo 13
Naples 12
San Paolo di Civitate 12
Athens 11
Barcelona 11
Gainesville 11
Jefferson 11
Adana 10
Chapel Hill 10
Hong Kong 10
Houston 10
Urbino 10
Bangkok 9
Buffalo 9
Incheon 9
Ulsan 9
Berlin 8
Budapest 8
London 8
Perugia 8
Shanghai 8
St Louis 8
Washington 8
Wilmington 8
Delhi 7
Edmonton 7
Millbury 7
Mumbai 7
Munich 7
Paris 7
Princeton 7
Tokyo 7
Boston 6
Des Moines 6
Kampala 6
Lappeenranta 6
Lawrence 6
Limassol 6
Mainz 6
Marietta 6
San Diego 6
Seattle 6
Terracina 6
Toronto 6
Viterbo 6
Andover 5
Arezzo 5
Beijing 5
Cagliari 5
Caserta 5
Dhaka 5
Falkenstein 5
Frankfurt am Main 5
Gujranwala 5
Kolkata 5
Melbourne 5
Montreal 5
Palo Alto 5
Woodbridge 5
Yubileyny 5
Al Mansurah 4
Ann Arbor 4
Aprilia 4
Birmingham 4
Bologna 4
Cairo 4
Chicago 4
Decatur 4
Durham 4
Fort Worth 4
Genoa 4
Gwanak-gu 4
Hobart 4
Islamabad 4
Katwijk aan Zee 4
Kecioeren 4
Los Angeles 4
Messina 4
Miami 4
Totale 1.500
Nome #
Analytical characterization of an inulin-type fructooligosaccharide from root-tubers of Asphodelus ramosus L 116
Investigation of Commiphora myrrha (Nees) Engl. oil and its main components for antiviral activity 110
Design, synthesis and biological evaluation of new pyrimidine derivatives as anticancer agents 107
New Inhibitors of the human p300/CBP acetyltransferase are selectively active against the Arabidopsis HAC proteins 102
Anti-tumoral effects of a (1H-pyrrol-1-yl)methyl-1H-benzoimidazole carbamate ester derivative on head and neck squamous carcinoma cell lines 94
Pyrrolyl and indolyl α-γ-diketo acid derivatives acting as selective inhibitors of human carbonic anhydrases IX and XII 93
From Iloperidone to new Sigma1 agonists: a structure-based approach for Huntington's disease treatment. 90
Inhibition of Leishmania infantum Trypanothione Reductase by New Aminopropanone Derivatives Interacting with the NADPH Binding Site 81
New blood-brain-barrier permeable compounds as Naegleria Fowleri CYP51 inhibitors. 75
Quinolinonyl non-diketo acid derivatives as Inhibitors of HIV-1 ribonuclease H and polymerase functions of reverse transcriptase 73
Ultrastructural damages to H1N1 influenza virus caused by vapor essential oils 73
Aminopyrimidine derivatives as new protein kinase inhibitors endowed with anticancer activity. 71
New Thiazolidine-4-One Derivatives as SARS-CoV-2 Main Protease Inhibitors 60
Discovery of new small molecules as anti-SARS-CoV-2 agents inhibiting ACE2-spike binding. 59
Small molecule derivatives as dual inhibitors of SARS-CoV-2 nsp13 blocking viral replication. 58
Recent advances in recovery of lycopene from tomato waste. A potent antioxidant with endless benefits 56
Pyrimidine-based compounds as new promising protein kinase inhibitors for cancer treatment. 55
Design and synthesis of tetrahydro-β-carbolines derivatives as PDIA inhibitors. 53
Dual HIV-1 integrase catalytic site and integrase-RNA interaction inhibitors. 52
Discovery of quinolinonyl derivatives as anti-HIV-1 inhibitors endowed with an innovative mechanism of action. 52
Diketo acid inhibitors of nsp13 of SARS-CoV-2 block viral replication 47
Novel nsp13 inhibitors capable of blocking viral replication of SARS-CoV-2. 46
null 45
Identification of novel aminopyrimidine derivatives as protein kinase inhibitors blocking cell growth. 44
Quinolinonyl derivatives as dual inhibitors of the HIV-1 integrase catalytic site and integrase-RNA interactions. 42
Pyrrole derivatives targeting the Endocannabinoid System (ECS) in Prostate Cancer Cells 40
Identification of novel pyrimidine-based compounds as SARS-CoV-2 RNA-dependent RNA polymerase inhibitors. 37
Different approaches to target SARS-CoV-2: discovery of new small molecules as antiviral agents. 37
Miconazole-like compounds as brain permeable anti-Naegleria Fowleri agents targeting CYP51. 37
New diketo acid derivatives as dual SARS-CoV-2 nsp13 inhibitors active against viral replication. 37
Discovery of small molecule derivatives as SARS-CoV-2 nsp13 inhibitors: a new strategy to develop broad-spectrum antiviral agents 36
Structure-based drug design of new sigma-1 receptor agonists. 36
Synergistic Effects of Caffeine in Combination with Conventional Drugs: Perspectives of a Drug That Never Ages 33
Structure-activity relationships of indolyl derivatives as SARS-CoV-2 nsp13 inhibitors 33
Miconazole-like scaffold is a promising lead for Naegleria fowleri-specific CYP51 inhibitors 31
Design and synthesis of brain permeable anti-Naegleria fowleri agents targeting CYP51 for primary amoebic meningoencephalitis treatment. 30
Design and synthesis of novel compounds targeting both AURKA and HDAC enzymes. 27
From iloperidone to new sigma-1 receptor agonists using a structure-based approach. 26
Unvealing newly discovered small molecules as ACE2-spike inhibitors against SARS-CoV-2. 23
From iloperidone to new sigma-1 receptors agonists: a structure-based approach. 23
Diketo acid heterocyclic derivatives as new SARS-CoV-2 nsp13 inhibitors blocking viral replication. 23
Nitrogen-based derivatives as RNA-dependent RNA polymerase inhibitors of SARS-CoV-2. 23
New nitrogen based derivatives as SARS-CoV-2 nsp13 inhibitors 20
DEVELOPING NOVEL COMPOUNDS TARGETING AURKA AND HDAC ENZYMES SIMULTANEOUSLY 20
Role of a Novel Heparanase Inhibitor on the Balance between Apoptosis and Autophagy in U87 Human Glioblastoma Cells 19
NEW THIAZOLIDINE-4-ONE DERIVATIVES CAPABLE OF INHIBITING SARS-CoV-2 MPRO 19
Inhibitors of protein-protein interaction between the human receptor ACE2 and the viral protein spike: a new frontier in the fight against SARS-CoV-2. 17
Design and synthesis of new aryl derivatives as inhibitors of protein disulfide isomerase 17
Identification of new heterocyclic compounds as protein disulfide isomerase A inhibitors. 16
Targeting protein disulfide isomerase A with newly designed and synthesized aryl derivatives 14
New quinolinonyl derivatives as SARS-CoV-2 nsp13 inhibitors 13
Indolyl derivatives as SARS-CoV-2 nsp13 inhibitors active against viral replication 12
Quinolinonyl Derivatives as Dual Inhibitors of the HIV-1 Integrase Catalytic Site and Integrase-RNA interactions 11
From Iloperidone to new Sigma1 agonists: a structre-based approach for Huntington’s disease treatment. 8
Totale 2.472
Categoria #
all - tutte 9.311
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.311


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202161 0 0 0 0 0 0 0 5 2 27 7 20
2021/2022135 13 10 9 15 8 1 12 11 9 1 14 32
2022/2023341 19 30 17 34 30 28 26 55 25 30 27 20
2023/2024877 15 18 51 34 50 244 158 65 35 69 73 65
2024/20251.058 52 83 92 105 423 177 126 0 0 0 0 0
Totale 2.472